| Literature DB >> 32429250 |
Maki Yamaguchi1, Masako Kimura2, Tetsuo Ohno3, Naoya Nakahara1, Nobutake Akiyama4, Shigeru Takemori1, Naoto Yagi5.
Abstract
X-ray diffraction and tension measurement experiments were conducted on rat left ventricular skinned fibers with or without "troponin-T treatment," which exchanges the endogenous troponin T/I/C complex with exogenous troponin-T. These experiments were performed to observe the structural changes in troponin-T within a fiber elicited by contractile crossbridge formation and investigate the abnormality of hypertrophic cardiomyopathy-related troponin-T mutants. The intensity of the troponin reflection at 1/38.5 nm-1 was decreased significantly by ATP addition after treatment with wild-type or mutant troponin-T, indicating that crossbridge formation affected the conformation of troponin-T. In experiments on cardiac fibers treated with the hypertrophic cardiomyopathy-related mutants E244D- and K247R-troponin-T, treatment with K247R-troponin-T did not recruit contracting actomyosin to a greater extent than wild-type-troponin-T, although a similar drop in the intensity of the troponin reflection occurred. Therefore, the conformational change in K247R-troponin-T was suggested to be unable to fully recruit actomyosin interaction, which may be the cause of cardiomyopathy.Entities:
Keywords: X-ray diffraction; cardiomyopathy; skinned fiber; troponin
Mesh:
Substances:
Year: 2020 PMID: 32429250 PMCID: PMC7278983 DOI: 10.3390/ijms21103520
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Atomic structure of cardiac troponin core domain visualized by VMD (version 1.9.3) based on the crystal structure (PDB ID; 1J1E). (A) troponin core domain with 244th amino acid (indicated by arrow) of TnT mutated from glutamate to aspartate (shown as space filling model in warm colors). (B) troponin core domain with 247th amino acid (indicated by arrow) of troponin-T (TnT) mutated from lysine to arginine (shown as space filling model in warm colors). TnT and troponin-I (TnI) in the “IT arm” domain are colored in pink and green, respectively. Residues in TnI that interacted with mutated residues in TnT are shown as space filling model in green.
Figure 2(A,B) Representative X-ray diffraction patterns obtained from rat cardiac skinned muscle fibers in the Rigor (A) and ATP (B) solutions without TnT-treatment. Meridional reflection of troponin at 1/38.5 nm−1 and equatorial reflections of 1.1 and 1.0 are indicated by arrows. C–D: Representative X-ray diffraction images obtained from rat cardiac skinned muscle fibers in the Rigor (C) and ATP (D) solutions after TnT-treatment with wild-type TnT. Meridional reflection of troponin at 1/38.5 nm−1 and equatorial reflections of 1.1 and 1.0 are indicated by arrows.
Figure 3(A–D) Intensity profiles of the 38.5 nm troponin reflection of cardiac skinned muscle fibers along the equatorial axis in the Rigor (black) and ATP (purple) solution with or without TnT-treatment. Intensity is represented as relative value to integrated intensity of 5.9 nm actin layer line in the Rigor solution for each fiber. (A) Without treatment. Averaged values and standard error of the mean (S.E.M.) from five fibers are shown. (B) TnT-treatment with wild-type TnT. Averaged values and S.E.M. from eight fibers are shown. (C) TnT-treatment with E244D-TnT. Averaged values and S.E.M. from nine fibers are shown. (D) TnT-treatment with K247R-TnT. Averaged values and S.E.M. from nine fibers are shown. (E) Integrated intensities of the 38.5 nm troponin reflection of cardiac skinned muscle fibers in the Rigor (black) and ATP (purple) solution with or without TnT-treatment by wild-type TnT, E244D-TnT, or K247R-TnT. Averaged values and S.E.M. from eight (wild-type TnT treatment), nine (E244D-TnT treatment), and nine (K247R-TnT treatment) fibers are shown. * and ** indicate significant difference with p < 0.02 and p < 0.01 by paired t-test respectively.
Figure 4(A) Representative tension recording of cardiac skinned muscle fibers before and after TnT-treatment. The fibers in the ATP solution were transferred to Maximally-activating solution (during the period indicated as the black bar labeled “Maximally-activating”) to check contractility of the fibers, then TnT-treatment was conducted (during the period indicated as gray bar labeled “troponin-T treatment”). After the TnT-treatment, the fiber was transferred to Rigor solution, then soaked in ATP solution (during the period indicated as the gray bar labeled “ATP +”) to measure amplitude of Ca2+-independent tension. Finally, the fiber was soaked in Maximally-activating solution (during the period indicated as the black bar labeled “maximally-activating”) to measure amplitude of maximally developed tension of the fibers. (B) Summarized results of relative tension in the presence of ATP (ATP solution) to maximally developed tension in the presence of ATP and Ca2+ (Maximally-activating solution). Averaged value and S.E.M. for five (without treatment), seven (treatment with wild-type TnT), seven (treatment with E244D-TnT), and nine (treatment with K247R-TnT) fibers. ** represents p < 0.01 by ANOVA. (C) Intensity ratio of the 1.1 and 1.0 equatorial reflections of the cardiac skinned muscle fibers in Rigor (black) and ATP (purple) solutions before and after TnT-treatment with wild-type, E244D-, or K247R-TnT. Averaged values and S.E.M. from five (without treatment), eight (wild-type), nine (E244D-TnT treated group), and nine (K247R-TnT treated group) fibers are shown. (D) Intensity ratio of the 1.1 and 1.0 equatorial reflections of the cardiac skinned muscle fibers in the presence of ATP before and after TnT-treatment with wild-type, E244D-, or K247R mutant TnT, represented as a relative value to the ratio in the absence of ATP. Averaged values and S.E.M. from five (without treatment), eight (wild-type TnT treatment), nine (E244D-TnT treatment), and nine (K247R-TnT treatment) fibers are shown.